RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET ANALYSIS

Name: Recombinant Therapeutic Antibodies And Proteins Market Size and Trends
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy

Recombinant Therapeutic Antibodies and Proteins Market, by Drug Class (Plasma Protein, Growth factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Enzyme, Coagulation Factors, and Others), by Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, trends, and Forecast to 2026

Published In : Jul 2018
Code : CMI1981
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Recombinant Therapeutic Antibodies And Proteins MarketSize and Trends

The global recombinant therapeutic antibodies and proteins market size was valued at US$ 91.2 billion in 2017, and is expected to witness a robust CAGR of 12.2% over the forecast period (2018 – 2026).

Figure 1. Global Recombinant Therapeutic Antibodies and Proteins Market Share (%), By Drug Class